Industries/Biotech/GTM Strategy
15+ Life science clients served

Go-to-Market Strategy for Biotech Startups

End-to-end GTM planning covering ICP definition, channel selection, messaging, launch sequencing, and revenue milestones. For Biotech companies, this means navigating challenges unique to your category: Scientific credibility and Investor vs. commercial messaging.

Life sciences companies, drug discovery platforms, and biotechnology innovators. Generic marketing agencies don't understand the nuances of Biotech — the buyer personas, the sales cycles, the proof points that matter. Cactus Marketing has worked with 15+ Life science clients served and built a playbook specifically for this category.

Biotech Marketing Challenges We Solve

Scientific credibility
Investor vs. commercial messaging
Long development timelines
Regulatory milestones as marketing triggers

What Our GTM Strategy Engagement Delivers

ICP and buyer persona definition
Competitive positioning map
Channel strategy and prioritization
Launch playbook with 90-day execution plan
Revenue milestone framework

We've worked with 15+ Life science clients served across the full company lifecycle — from pre-revenue through post-IPO. Our team understands your buyers, your competitive dynamics, and the marketing levers that drive results in Biotech.

Ready to accelerate your Biotech growth?

Book a free 30-minute call. We'll review your current marketing, share specific GTM Strategy strategies for Biotech companies, and give you a concrete roadmap.

Book a free strategy call →